RapidScan detects SARS-CoV-2 the disease-causing COVID-19.
Our non-invasive & contactless sensor technology can detect all known SARS-CoV-2 strains in under 10 seconds.
Perfect for airports, railway & bus stations, sports stadiums, shopping malls & large businesses.
RapidScan supports Track & Trace initiatives by finding people infected with COVID-19 before they show symptoms.
Our patent-pending technology is now available for commercial licensing. Our business is looking for business angels, equity investors and grants to support the software development, manufacturing, marketing & launch of RapidScan.
We are actively reaching out to government ministers and civil servants responsible for pandemic planning, travel & healthcare in countries interested in a screening solution.
MEDTRAC RapidScan technology can help reduce the rate of transmission of the virus causing COVID-19. RapidScan can help prevent new waves of infection.
The platform is updated daily with new mutations as they are found.
Our Current Development Plan
MEDTRAC is a company bringing a range of contactless non-invasive AI-assisted diagnostic systems to market.
Click on the link below to download a brochure.